| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/JAMA.256.24.3358 |
| P698 | PubMed publication ID | 2946876 |
| P2093 | author name string | M Bigby | |
| H Jick | |||
| K Arndt | |||
| S Jick | |||
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | collaboration | Q1145523 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 3358-3363 | |
| P577 | publication date | 1986-12-01 | |
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982 | |
| P478 | volume | 256 |
| Q47370122 | A 6-month prospective survey of cutaneous drug reactions in a hospital setting |
| Q37614235 | A review of adverse cutaneous drug reactions resulting from the use of interferon and ribavirin |
| Q40114511 | A six-month prospective study to find out the treatment outcome, prognosis and offending drugs in toxic epidermal necrolysis from an urban institution in kolkata |
| Q34271822 | Absence of Cross-Reactivity between Sulfonamide Antibiotics and Sulfonamide Nonantibiotics |
| Q38629246 | Adverse cutaneous drug eruptions: current understanding. |
| Q34529792 | Adverse cutaneous drug reactions: Eight year assessment in hospitalized patients |
| Q87816538 | Adverse drug reactions in an emergency medical dispatching centre |
| Q41094152 | Adverse reactions to antibiotics: is the patient really allergic? |
| Q77401752 | Allergic dermatoses |
| Q33928992 | Allergic emergencies encountered by the dermatologist. Severe cutaneous adverse drug reactions |
| Q38083590 | Allergic reactions to iodinated contrast media: premedication considerations for patients at risk |
| Q37102419 | Allergies to sulfonamide antibiotics and sulfur-containing drugs |
| Q71907252 | Anaphylaxis to erythromycin |
| Q37310473 | Antibiotic allergies in the medical record: effect on drug selection and assessment of validity |
| Q90592768 | Antibiotic allergy |
| Q31974254 | Antibiotic side effects |
| Q40891387 | Application of in vitro human skin models to dermal irritancy: a brief overview and future prospects |
| Q34709841 | Challenge Test Results in Patients With Suspected Penicillin Allergy, but No Specific IgE. |
| Q72992286 | Characteristics of bacterial skin infections in children compared to adults at a tertiary dermatologic center |
| Q33980619 | Chronic kidney disease in gout in a managed care setting |
| Q44996007 | Clinical application of static fluorescence-based cytometry, Cellscan, in cutaneous adverse drug reaction |
| Q35502326 | Clinical applications of drug desensitization in the Asia-Pacific region |
| Q43733448 | Clinical evaluation of Pharmacia CAP System RAST FEIA amoxicilloyl and benzylpenicilloyl in patients with penicillin allergy. |
| Q45112443 | Combined in vivo and in vitro approach for the characterization of penicillin-specific polyclonal lymphocyte reactivity: tolerance tests with safe penicillins instead of challenge with culprit drugs |
| Q51803601 | Cutaneous Drug Reactions in the Elderly. |
| Q43451022 | Cutaneous adverse drug reactions in the elderly: a retrospective analysis in Thailand |
| Q38120676 | Cutaneous drug reactions in children: an update. |
| Q67568162 | Cutaneous drug reactions. An attempt to quantitative estimation |
| Q40601228 | Cutaneous manifestations of infectious diseases: approach to the patient with fever and rash |
| Q36053675 | Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions |
| Q41461458 | Dermatomyositis and Paclitaxel-Induced Cutaneous Drug Eruption Associated with Metastatic Breast Cancer |
| Q36021140 | Drug Eruptions: An 8-year Study Including 106 Inpatients at a Dermatology Clinic in Turkey |
| Q33552260 | Drug Reaction with Eosinophilia and Systemic Symptoms: DRESS following Initiation of Oxcarbazepine with Elevated Human Herpesvirus-6 Titer |
| Q35096508 | Drug allergy in a general hospital: Results of a novel prospective inpatient reporting system |
| Q40187782 | Drug reaction with eosinophilia and systemic symptoms syndrome (DRESS) syndrome associated with azithromycin presenting like septic shock: a case report |
| Q40682721 | Drug-induced severe skin reactions. Incidence, management and prevention |
| Q43521925 | Drug-induced toxic epidermal necrolysis |
| Q34976470 | Epidemiology and risk factors for drug allergy |
| Q43450587 | Experience with parenteral and sequential parenteral-oral amoxicillin/clavulanate (augmentin) in hospitalized patients |
| Q36890817 | Female sex as a risk factor for penicillin allergy |
| Q40701406 | Follicular toxic pustuloderma associated with allopurinol |
| Q22306051 | Hypersensitivity Reactions to Beta-Lactam Antibiotics |
| Q39159544 | Identification of MHC Haplotypes Associated with Drug-induced Hypersensitivity Reactions in Cynomolgus Monkeys |
| Q34122409 | Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment |
| Q35606976 | Is eosinophilia helpful in diagnosing drug eruptions? |
| Q28478563 | Justified concern or exaggerated fear: the risk of anaphylaxis in percutaneous treatment of cystic echinococcosis-a systematic literature review |
| Q37903757 | Late adverse reactions to intravascular iodine based contrast media: an update |
| Q34564728 | Management of cutaneous drug reactions |
| Q35177407 | Mechanisms in cutaneous drug hypersensitivity reactions |
| Q40375135 | Mechanisms of drug eruptions: Part I. |
| Q40563073 | Mechanisms of unpredictable adverse drug reactions |
| Q64241597 | Mild cutaneous reactions to drugs |
| Q33796710 | Mucocutaneous manifestations of Dengue fever |
| Q92644039 | Outcomes from an inpatient beta-lactam allergy guideline across a large US health system |
| Q67930978 | Post-marketing surveillance of quinolones 1988–1990 |
| Q44357984 | Prescribing errors in patients with documented drug allergies: comparison of ICD-10 coding and written patient notes |
| Q36313040 | Principles of pharmacotherapy: III. Drug allergy. |
| Q55068342 | RNA expression profiling in sulfamethoxazole-treated patients with a range of in vitro lymphocyte cytotoxicity phenotypes. |
| Q35089165 | Rosacea-like facial rash related to metformin administration in a young woman. |
| Q34103378 | Severe delayed-onset hypersensitivity reactions to amoxicillin in children. |
| Q37863710 | Skin manifestations of drug allergy |
| Q34666551 | Skin manifestations of drug reactions |
| Q44368559 | Skin reactions to co-trimoxazole |
| Q44756460 | Skin test evaluation in nonimmediate allergic reactions to penicillins. |
| Q41788289 | Slow acetylator phenotype and genotype in HIV-positive patients with sulphamethoxazole hypersensitivity |
| Q34744355 | Strategies for diagnosing and treating suspected acute bacterial sinusitis: a cost-effectiveness analysis |
| Q89017410 | Sulfonamide Drug Allergy |
| Q39830842 | Update on the management of antibiotic allergy |
| Q81258003 | [Drug allergies. Clinical aspects, pathophysiology and treatment of cutaneous manifestations] |
| Q87860040 | [Drug-induced pruritus] |
| Q89001465 | [Triggers of exanthematous drug eruptions: Stop intake, treat through or desensitization?] |
Search more.